Table 3.
The network meta-analysis results (presented as odds ratio) for all-cause mortality
| ABLC | AmB | Caspofungin | Fluconazole | Itraconazole | L-AmBa | L-AmBb | Micafungin | NAT | Voriconazole |
|---|---|---|---|---|---|---|---|---|---|
| 2.13 (0.25, 15.53) | |||||||||
| 4.00 (0.36, 30.31) | 2.00 (0.29, 9.16) | ||||||||
| 0.82 (0.03, 13.01) | 0.44 (0.04, 3.16) | 0.24 (0.01, 2.79) | |||||||
| 2.23 (0.19, 18.54) | 1.06 (0.32, 2.75) | 0.55 (0.08, 4.32) | 2.38 (0.27, 32.66) | ||||||
| 2.30 (0.13, 30.41) | 1.00 (0.13, 8.32) | 0.53 (0.05, 6.77) | 2.51 (0.14, 58.87) | 0.97 (0.10, 10.44) | |||||
| 2.92 (0.51, 17.19) | 1.44 (0.43, 4.65) | 0.72 (0.24, 3.10) | 3.17 (0.38, 54.22) | 1.34 (0.31, 7.65) | 1.45 (0.18, 10.99) | ||||
| 2.28 (0.10, 27.64) | 1.10 (0.11, 5.97) | 0.53 (0.04, 5.76) | 2.53 (0.16, 43.72) | 1.03 (0.17, 4.87) | 1.14 (0.05, 15.78) | 0.72 (0.07, 5.08) | |||
| 1.57 (0.13, 26.34) | 0.79 (0.18, 4.60) | 0.41 (0.05, 5.77) | 1.93 (0.13, 34.81) | 0.74 (0.15, 6.87) | 0.73 (0.06, 12.62) | 0.55 (0.09, 4.65) | 0.69 (0.09, 14.59) | ||
| 2.49 (0.29, 24.91) | 1.12 (0.23, 8.07) | 0.58 (0.12, 6.07) | 2.68 (0.24, 74.04) | 1.08 (0.20, 11.04) | 1.16 (0.12, 15.57) | 0.78 (0.22, 4.00) | 1.03 (0.14, 18.98) | 1.49 (0.13, 15.91) |
ABLC Amphotericin B lipid complex, AmB Conventional amphotericin B, L-AmB Liposomal amphotericin B, NAT No antifungal treatment
a1 mg/kg/day; b3 mg/kg/day